GGrantIndex
← Leaderboards

Elizabeth Sally Ward

University Of Texas Sw Med Ctr/Dallas

$8,676,225
Attributed
$8,676,225
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200512
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$8,676,225 · 7

By mechanism

R01$8,555,656 · 5
P01$117,569 · 1
R13$3,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Sw Med Ctr/Dallas

Same institution · by research overlap

Others in their field

Top investigators on “Immunoglobulin G

Research focus

Immunoglobulin GLaboratory MouseMolecularBinding (Molecular Function)PlayAntibodiesCellsSurface Plasmon ResonanceGenerationsAutoimmunityEngineeringAntibody EngineeringFc ReceptorIn VivoPropertyMouse ModelReceptorComplexMediatingInsightSiteIn VitroInterestInvestigation

Grant awards (33)

Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases$212,283
R01 · FY2012 · AR · contact PI
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases$108,675
R01 · FY2012 · AR · contact PI
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases$328,268
R01 · FY2011 · AR · contact PI
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases$341,946
R01 · FY2010 · AR · contact PI
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases$169,825
R01 · FY2010 · AR · contact PI
2010 Antibody Biology and Engineering Gordon Research Conference$3,000
R13 · FY2010 · AI · contact PI
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases$345,400
R01 · FY2009 · AR · contact PI
Structure-function studies of human FcRn$362,764
R01 · FY2008 · AI · contact PI
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases$345,400
R01 · FY2008 · AR · contact PI
Structure-function studies of human FcRn$369,790
R01 · FY2007 · AI · contact PI
Antibody engineering: targeting Bacillus anthracis$332,812
R01 · FY2007 · AI · contact PI
Molecular Analysis of T Cell Recognition in EAE$295,832
R01 · FY2007 · AI · contact PI
Structure-function studies of human FcRn$380,835
R01 · FY2006 · AI · contact PI
Antibody engineering: targeting Bacillus anthracis$342,752
R01 · FY2006 · AI · contact PI
Molecular Analysis of T Cell Recognition in EAE$304,668
R01 · FY2006 · AI · contact PI
Structure-function studies of human FcRn$390,000
R01 · FY2005 · AI
Antibody engineering: targeting Bacillus anthracis$351,000
R01 · FY2005 · AI
Molecular Analysis of T Cell Recognition in EAE$312,000
R01 · FY2005 · AI
Structure-function studies of human FcRn$390,000
R01 · FY2004 · AI
Antibody engineering: targeting Bacillus anthracis$351,000
R01 · FY2004 · AI
Molecular Analysis of T Cell Recognition in EAE$312,000
R01 · FY2004 · AI
Molecular Analysis of T Cell Recognition in EAE$282,750
R01 · FY2003 · AI
Antibody engineering: targeting Bacillus anthracis$117,000
R01 · FY2003 · AI
STRUCTURE/FUNCTION STUDIES OF HUMAN FCRN$322,394
R01 · FY2002 · AI
IMPROVING SURFACE PLASMON RESONANCE TECHNOLOGY$220,374
R01 · FY2002 · GM
CORE--BIACORE FACILITY$0
P01 · FY2002 · AI
STRUCTURE/FUNCTION STUDIES OF HUMAN FCRN$313,003
R01 · FY2001 · AI
IMPROVING SURFACE PLASMON RESONANCE TECHNOLOGY$220,374
R01 · FY2001 · GM
CORE--BIACORE FACILITY$0
P01 · FY2001 · AI
STRUCTURE/FUNCTION STUDIES OF HUMAN FCRN$303,886
R01 · FY2000 · AI
IMPROVING SURFACE PLASMON RESONANCE TECHNOLOGY$231,076
R01 · FY2000 · GM
MOLECULAR ANALYSIS OF T CELL RECOGNITION IN EAE$197,549
R01 · FY2000 · AI
CORE--BIACORE FACILITY$117,569
P01 · FY2000 · AI